Judith Li

Judith Li has an extensive work experience in various companies and organizations. Judith started their career at Lilly Asia Ventures in 2013 as a Partner. Judith has served as a Board Director in several companies including ADARx Pharmaceuticals Inc. (since 2021), SciNeuro Pharmaceuticals (since 2020), Tmunity Therapeutics Incorporated (since 2016), Fortis (since 2016), Hong Kong Venture Capital and Private Equity Association (from 2017 to 2022), Gritstone bio (from 2017 to 2022), NextCure, Inc. (from 2015 to 2020), EScape Bio (from 2017 to 2019), and Just Biotherapeutics (from 2015 to 2019). Each role provided their with valuable experience in different sectors such as biotechnology, pharmaceuticals, and venture capital.

Judith Li has a Bachelor's degree in Neurobiology from Harvard University. Judith also holds a Masters of Business Administration degree from Harvard Business School.